article January 8, 2024
Linda McCarty featured in Applied Clinical Trials: Taxation Reform
The Time Is Now: Taxation Reform for Expanded Clinical Trial Access
“While taxation of clinical trial payments is not the only barrier preventing equitable access to clinical trials, it is one that is often overlooked and disregarded industry-wide. To truly expand clinical trial access to include historically underrepresented ethnic and racial minorities, we must address root-cause barriers, and this includes taxation.”
Javara’s Linda McCarty, JD, co-founder and chief legal officer, illuminates the detrimental impact of taxation on clinical research as it currently stands, and how we can approach taxation reform today for a healthier, more equitable future. Read more with Applied Clinical Trials!
Share